Marrone Bio Innovations, Inc. (NASDAQ:MBII) Raised to “Hold” at Zacks Investment Research

Marrone Bio Innovations, Inc. (NASDAQ:MBII) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, July 12th.

According to Zacks, “Marrone Bio Innovations Inc. develops environmentally safe bio-based products. The Company specializes in the discovery, development, and marketing of natural products for weed, pest, water resource, and plant disease management. It offers crop protection products for conventional and organic crop production, including herbicides for weed control, fungicides for plant disease control, nematicides for parasitic roundworm control, insecticides for insect and mite killers and plant growth regulators that growers use to increase crop yields, enhance plant health, manage pest resistance, and reduce chemical residues. Marrone Bio Innovations Inc. is headquartered in Davis, California. “

Several other research analysts also recently commented on MBII. Jefferies Group LLC reissued a “hold” rating and set a $2.50 price objective on shares of Marrone Bio Innovations in a report on Tuesday, May 2nd. HC Wainwright reissued a “buy” rating on shares of Marrone Bio Innovations in a report on Friday, May 12th. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $1.75.

Shares of Marrone Bio Innovations (MBII) traded down 1.77% on Wednesday, hitting $1.11. The stock had a trading volume of 71,001 shares. The company’s market capitalization is $34.80 million. Marrone Bio Innovations has a 52 week low of $0.82 and a 52 week high of $2.79. The company has a 50-day moving average of $1.18 and a 200 day moving average of $1.59.

COPYRIGHT VIOLATION WARNING: “Marrone Bio Innovations, Inc. (NASDAQ:MBII) Raised to “Hold” at Zacks Investment Research” was originally reported by Community Financial News and is the property of of Community Financial News. If you are viewing this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://www.com-unik.info/2017/08/12/marrone-bio-innovations-inc-nasdaqmbii-upgraded-at-zacks-investment-research-updated-updated-updated.html.

Marrone Bio Innovations Company Profile

Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.

Get a free copy of the Zacks research report on Marrone Bio Innovations (MBII)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

What are top analysts saying about Marrone Bio Innovations Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Marrone Bio Innovations Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit